SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Powerful medicines: the benefits, risks, and costs of prescription drugs
0 references·12 citing·47 second hop
Powerful medicines: the benefits, risks, and costs of prescription drugs (2005)Powerful medicines: the benefits, risks, …Small fish, big fish: The performance effects of the relative standing in partners' affiliate portfolios (2014)Small fish, big fish: The per…The Ethics of Intellectual Property Rights in an Era of Globalization (2013)The Ethics of Intellectual Pr…The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions? (2012)The logical underpinnings and…Vulnerability of Health to Market Forces (2011)Vulnerability of Health to Ma…Just-so Stories: Vaccines, Autism, and the Single-bullet Disorder (2010)Just-so Stories: Vaccines, Au…Beavers, Bubbles, Bees, and Moths (2009)Beavers, Bubbles, Bees, and M…Enabling TRIPs: The pharma–biotech–university patent coalition (2008)Enabling TRIPs: The pharma–bi…The Impact of the Cox-2 Inhibitor Issue on Perceptions of the Pharmaceutical Industry: Content Analysis and Communication Implications (2007)The Impact of the Cox-2 Inhib…Regulatory Errors with Endogenous Agendas (2007)Regulatory Errors with Endoge…Managing the Risks Associated with Using Biomedical Ethics Advice (2007)Managing the Risks Associated…University-Based Science and Biotechnology Products (2005)University-Based Science and …Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors (2004)Medicaid Prior-Authorization …The Child in America. (1929)Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association (1999)Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials (2003)Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES (2014)Vaccine hesitancy and emerging parental norms: A qualitative study in Taiwan (2022)Specification Tests in Econometrics (1978)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Interorganizational Imitation and Acquisitions of High‐tech Ventures (2017)Network Prominence, Bargaining Power, and the Allocation of Value Capturing Rights in High-Tech Alliance Contracts (2017)How to Join the Club: Patterns of Embeddedness and the Addition of New Members to Interorganizational Collaborations (2019)Abnormal economics in the health sector (1995)Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program (2006)Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases (2009)A systematic review of pooled procurement of medicines and vaccines: identifying elements of success (2022)Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities (2022)Geographic Variation in Expenditures for Physicians' Services in the United States (1993)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization? (2009)State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid (2010)The Age of Discontinuity. Guidelines to Our Changing Society (1970)Anarchy, State, and Utopia (1975)Pharmaceutical patenting and the transformation of American medical ethics (2016)Anarchy, State, and Utopia (2018)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting (2000)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Medical-Process Patents — Monopolizing the Delivery of Health Care (2006)Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation (2010)The valorization of non-patent intellectual property in academic medical centers (2020)The Strategy of Conflict (1960)The Social Amplification of Risk: A Conceptual Framework (1988)The Perception of Risk (2016)Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents (2018)An Inquiry into the Nature and Causes of the Wealth of Nations (1776)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)Social determinants of health inequalities (2005)The New Imperialism (2003)Selections from the Prison Notebooks (2007)Technoscience Rent: Toward a Theory of Rentiership for Technoscientific Capitalism (2019)Selections from the prison notebooks (2020)Essence of Decision: Explaining the Cuban Missile Crisis (1972)Investment under Uncertainty (1994)Investment Under Uncertainty. (1994)Confidence Games: How Does Regulation Constitute Markets? (2009)Approval regulation and endogenous consumer confidence: Theory and analogies to licensing, safety, and financial regulation (2010)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2004Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors111 cited
  • 2012The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions?87 cited
  • 2014Small fish, big fish: The performance effects of the relative standing in partners' affiliate portfolios59 cited
  • 2007Regulatory Errors with Endogenous Agendas57 cited
  • 2011Vulnerability of Health to Market Forces49 cited
  • 2005University-Based Science and Biotechnology Products37 cited
  • 2010Just-so Stories: Vaccines, Autism, and the Single-bullet Disorder30 cited
  • 2013The Ethics of Intellectual Property Rights in an Era of Globalization28 cited
  • 2008Enabling TRIPs: The pharma–biotech–university patent coalition27 cited
  • 2007The Impact of the Cox-2 Inhibitor Issue on Perceptions of the Pharmaceutical Industry: Content Analysis and Communication Implications27 cited
  • 2009Beavers, Bubbles, Bees, and Moths15 cited
  • 2007Managing the Risks Associated with Using Biomedical Ethics Advice8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work